The MD-14 approval documents are the most critical part of obtaining a CDSCO medical device import license in India. Form MD-14 is the official application submitted through the SUGAM portal by your Authorized Indian Agent (IAA) to the Central Drugs Standard Control Organization (CDSCO) for granting an import license in Form MD-15. Without a complete and accurate set of documents, your application faces rejection, queries, or delays of 3–9 months.
This detailed guide lists every required document for MD-14 approval in 2026 (based on Medical Devices Rules 2017, Fourth Schedule, and CDSCO checklists). Requirements vary slightly by device risk class (A, B, C, D), but the core list remains consistent for most imports, especially from US manufacturers leveraging FDA clearances.
Mandatory Documents for All MD-14 Applications (Fresh Import License)
These are required for all classes unless specified otherwise:
- Covering Letter On IAA letterhead, signed, explaining the purpose of the application, device details, and confirming compliance with MDR 2017.
- Application Form MD-14 Auto-generated and filled on the SUGAM portal after logging in and selecting “Import License.” Includes manufacturer details, device list (with GMDN codes, models, intended use), and IAA information.
- Fee Challan / Payment Proof Online payment receipt via SUGAM. Fees:
- Class A/B: ₹50,000–₹1,00,000 per device/site
- Class C/D: ₹1,00,000–₹2,00,000 per device/site (Exact amount depends on grouping and sites; pay before final submission.)
- Power of Attorney (PoA) From foreign manufacturer to IAA, notarized, apostilled (or authenticated by Indian Embassy/Magistrate of First Class). Must include undertaking as per Part I of Fourth Schedule of MDR 2017.
- Copy of IAA’s Wholesale / Manufacturing License IAA must hold valid MD-42 (wholesale) or manufacturing license (Form MD-5/9). Upload copy of license/registration certificate.
- Constitution Details of Authorized Agent Proof of IAA entity (e.g., company registration, GST certificate, PAN, address proof).
- Regulatory Certificates (Mandatory for Approval)
- Free Sale Certificate (FSC) / Marketing Authorization from country of origin (US FDA clearance/510(k)/PMA letter).
- Preferred: FSC from GHTF founding members (USA, EU, Canada, Japan, Australia, UK) – duly notarized.
- Overseas manufacturing site registration/establishment certificate from competent authority.
- Latest inspection/audit report (if available, within last 3 years).
- Quality Management System Certificate
- ISO 13485:2016 certificate of the actual manufacturing site (duly notarized).
- For CE-marked devices: Full Quality Assurance Certificate, CE Type Examination Certificate, CE Design Certificate (as applicable).
- Declaration of Conformity Issued by the manufacturer, confirming compliance with essential safety/performance principles.
- Plant Master File (PMF) As per Appendix I of Fourth Schedule – details manufacturing site layout, equipment, utilities, QMS processes.
- Device Master File (DMF) As per Appendix II of Fourth Schedule – comprehensive technical file including:
- Executive Summary
- Descriptive information & intended use
- Justification for device grouping
- Product specifications (variants, accessories)
- Substantial equivalence (predicate device)
- Labeling & IFU (Instructions for Use) – English + Hindi if required
- Design & manufacturing info
- Essential Principles checklist
- Risk management summary (ISO 14971)
- Verification/validation data
- Biocompatibility (if applicable)
- Medicinal substances / TSE-BSE (if applicable)
- Sterilization validation
- Software validation (if applicable)
- Preclinical/animal studies
- Stability data (real-time/accelerated)
- Clinical evidence
- Post-market surveillance / vigilance data
- Batch release certificates / CoA for 3 consecutive batches
- Any Additional Documents
- Copy of Form MD-27 permission (if investigational device)
- Batch testing reports or stability protocols (Class C/D often requested)
Class-Specific Notes (2026)
- Class A (non-sterile, non-measuring): Minimal scrutiny; basic FSC + QMS + labeling often sufficient.
- Class A (sterile/measuring), Class B: Add sterilization/biocompatibility validation.
- Class C & D: Full DMF + PMF mandatory; CDSCO often requests site inspection or FDA report acceptance. Clinical data strongly preferred.
Submission Format & Tips
- Upload PDFs only (max 5 MB per file).
- All foreign documents must be notarized + apostilled.
- Labeling must comply with Indian rules (manufacturer details, importer name/address, license number once granted).
- Use GMDN codes accurately for grouping to reduce fees.
Common Rejection Reasons (Avoid These!)
- Incomplete Power of Attorney or missing apostille.
- FSC not matching device models listed in MD-14.
- Missing ISO 13485 or QMS proof.
- Labeling/IFU not in English or non-compliant.
- No batch release certificates for higher classes.
Post-Approval (MD-15 Granted)
- License valid 5 years.
- Report changes (design, site) via Form MD-26.
- Maintain vigilance reporting and import records.
US manufacturers often succeed faster by appointing an experienced IAA early and preparing a robust DMF. For Class C/D devices, expect 6–9 months; Class A/B can be 3–6 months with clean submissions.
Need Help with Your MD-14 Documents? Contact Us Today! Our Delhi-based team specializes in CDSCO import licenses for US exporters. We prepare dossiers, handle SUGAM filings, respond to queries, and ensure 100% compliance.
Free initial consultation: Send your device details for classification & document gap analysis. We’ve helped 200+ US firms secure MD-15 approvals.
By Mark Smith Follow us on X @realnewshubs and subscribe for push notifications